Literature DB >> 18245476

Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.

Cristina M Contreras1, Sushma Gurumurthy, J Marshall Haynie, Lane J Shirley, Esra A Akbay, Shana N Wingo, John O Schorge, Russell R Broaddus, Kwok-Kin Wong, Nabeel Bardeesy, Diego H Castrillon.   

Abstract

Mutations in the LKB1 tumor suppressor gene result in the Peutz-Jeghers syndrome, an autosomal dominant condition characterized by hamartomatous polyps of the gastrointestinal tract and a dramatically increased risk of epithelial malignancies at other sites, including the female reproductive tract. Here we show that female mice heterozygous for a null Lkb1 allele spontaneously develop highly invasive endometrial adenocarcinomas. To prove that these lesions were indeed due to Lkb1 inactivation, we introduced an adenoviral Cre vector into the uterine lumen of mice harboring a conditional allele of Lkb1. This endometrial-specific deletion of the Lkb1 gene provoked highly invasive and sometimes metastatic endometrial adenocarcinomas closely resembling those observed in Lkb1 heterozygotes. Tumors were extremely well differentiated and histopathologically distinctive and exhibited alterations in AMP-dependent kinase signaling. Although Lkb1 has been implicated in the establishment of cell polarity, and loss of polarity defines most endometrial cancers, Lkb1-driven endometrial cancers paradoxically exhibit (given their highly invasive phenotype) normal cell polarity and apical differentiation. In human endometrial cancers, Lkb1 expression was inversely correlated with tumor grade and stage, arguing that Lkb1 inactivation or down-regulation also contributes to endometrial cancer progression in women. This study shows that Lkb1 plays an important role in the malignant transformation of endometrium and that Lkb1 loss promotes a highly invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245476     DOI: 10.1158/0008-5472.CAN-07-5014

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  STE20-related kinase adaptor protein α (STRADα) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells.

Authors:  Carrie M Eggers; Erik R Kline; Diansheng Zhong; Wei Zhou; Adam I Marcus
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

2.  Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Authors:  Adrienne S McCampbell; Heather A Harris; Judy S Crabtree; Richard C Winneker; Cheryl L Walker; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

Review 3.  The LKB1 complex-AMPK pathway: the tree that hides the forest.

Authors:  Michaël Sebbagh; Sylviane Olschwang; Marie-Josée Santoni; Jean-Paul Borg
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Inactivation of the LKB1-AMPK signaling pathway does not contribute to salivary gland tumor development - a short report.

Authors:  Natascha Cidlinsky; Giada Dogliotti; Tobias Pukrop; Rudolf Jung; Florian Weber; Michael P Krahn
Journal:  Cell Oncol (Dordr)       Date:  2016-08-01       Impact factor: 6.730

5.  A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.

Authors:  Hailing Cheng; Pixu Liu; Fan Zhang; Erbo Xu; Lynn Symonds; Carolynn E Ohlson; Roderick T Bronson; Sauveur-Michel Maira; Emmanuelle Di Tomaso; Jane Li; Andrea P Myers; Lewis C Cantley; Gordon B Mills; Jean J Zhao
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

6.  Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells.

Authors:  Imoh S Okon; Kathleen A Coughlan; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

7.  Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.

Authors:  Brandon Faubert; Emma E Vincent; Takla Griss; Bozena Samborska; Said Izreig; Robert U Svensson; Orval A Mamer; Daina Avizonis; David B Shackelford; Reuben J Shaw; Russell G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

8.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

9.  SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.

Authors:  Hailing Cheng; Pixu Liu; Zhigang C Wang; Lihua Zou; Stephanie Santiago; Victoria Garbitt; Ole V Gjoerup; J Dirk Iglehart; Alexander Miron; Andrea L Richardson; William C Hahn; Jean J Zhao
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

Review 10.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.